Conditions: Breast Cancer
Interventions: Drug: SHR- A1811; Drug: PCbHP; Drug: SHR- A1811+ Pyrotinib
Sponsors: Fudan University
Not yet recruiting
Interventions: Drug: SHR- A1811; Drug: PCbHP; Drug: SHR- A1811+ Pyrotinib
Sponsors: Fudan University
Not yet recruiting

